More Likely to 5x First: Novavax vs. Ocugen
Biotech companies are ripe with innovation. And sometimes that can lead to tremendous share gains. The two stocks I'll talk about here -- Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) -- both have soared in recent years on optimism about potentially game-changing products.
But when their programs failed to meet investors' expectations, Novavax and Ocugen shares came crashing back down to Earth. These companies may be down right now, but they're not out. In fact, from current levels, they have room to run.
Which one is more likely to increase fivefold first? Let's find out.
Source Fool.com
